Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 17, 2023

BUY
$151.05 - $180.26 $284,729 - $339,790
1,885 Added 14.43%
14,948 $2.32 Million
Q4 2022

Feb 16, 2023

BUY
$160.2 - $179.79 $29,636 - $33,261
185 Added 1.44%
13,063 $2.31 Million
Q3 2022

Nov 15, 2022

BUY
$161.33 - $179.52 $263,774 - $293,515
1,635 Added 14.54%
12,878 $2.1 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $268,263 - $296,685
-1,595 Reduced 12.42%
11,243 $1.99 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $268,263 - $296,685
1,595 Added 14.19%
12,838 $2.28 Million
Q1 2022

May 23, 2022

BUY
$158.14 - $179.59 $147,386 - $167,377
932 Added 9.04%
11,243 $1.99 Million
Q4 2021

Feb 16, 2022

BUY
$155.93 - $173.01 $188,831 - $209,515
1,211 Added 13.31%
10,311 $1.76 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $290,700 - $323,046
-1,800 Reduced 16.51%
9,100 $1.47 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $159,480 - $171,070
1,000 Added 10.1%
10,900 $1.8 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $367,368 - $409,152
2,400 Added 32.0%
9,900 $1.63 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $1.03 Million - $1.18 Million
7,500 New
7,500 $1.18 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Castellan Group Portfolio

Follow Castellan Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castellan Group, based on Form 13F filings with the SEC.

News

Stay updated on Castellan Group with notifications on news.